2020 5-star guard Priscilla Williams verbally commits to Syracuse

first_img Facebook Twitter Google+ Published on September 16, 2019 at 8:00 pm Contact David: ddschnei@syr.edu Five-star guard Priscilla Williams has verbally committed to Syracuse, Williams announced via an Instagram post on Monday afternoon. Williams is ranked third among guards and 11th overall in the 2020 class, according to the espnW 100 list. The 6-foot-2 guard also considered Southern Methodist, Louisville, Mississippi State and Florida State. Syracuse head coach Quentin Hillsman retweeted a screenshot of a scouting report saying “Williams can lead from the guard position, score off the dribble [and] spread the floor with the deep ball.” ESPN’s most recent player evaluations from July describe Williams as an “athletic guard [with a] feathery touch” and that her “mid-range game moves beyond the arc.”Williams is the second player to choose Syracuse in the class of 2020, joining guard Faith Blackstone, a four-star recruit, according to espnW 100.The Branson, Missouri native could join a Syracuse backcourt that includes Kiara Lewis and Emily Engstler, both of whom have eligibility through the 2020-21 season. The Orange’s All-Atlantic Coast Conference point guard Tiana Mangakahia, who will miss this season as she continues to undergo treatment for breast cancer, announced on Aug. 20 she plans to play for SU in the 2020-21 season.AdvertisementThis is placeholder textAs a junior at Branson High School, Williams averaged 27.8 points and 10.1 rebounds per game, sunk 52 three-pointers and recorded a school-record 51 points in a game. She was named to USA Today’s All-USA Missouri Girls Basketball Team and the Missouri Basketball Coaches Association’s Class 5 All-State team in 2019. Commentslast_img read more


Knicks fined $50K for violating NBA’s media policy

first_img Knicks welcome RJ Barrett to Madison Square Garden with emotional tribute video The Knicks have been fined $50,000 for violating the NBA’s media policy following the NBA Draft, the league announced Monday.NBA rules state that teams must allow equal access to all members of the media, but during Friday’s post-draft conference, the Knicks barred the New York Daily News from joining the conference. NBA stopped using term ‘owner’ in favor of ‘governor,’ Adam Silver says According to the league, the Knicks have “agreed to comply with NBA Media Access Rules moving forward.”The team released its own statement after the fine was announced, calling the situation a misunderstanding. Related News Kawhi Leonard free agency rumors: LA billboard woos ‘King of SoCal’ for Clippers “The Knicks acknowledge that we did not comply with the NBA’s media policy, and made an error in interpreting Friday’s announcement as an invite only event,” the statement said. “As we do throughout the year, we have and will continue to provide access to credentialed media as per the League’s policy.” It’s not the first time the Knicks — specifically team owner James Dolan — and the media have had a public fued. Dolan recently prevented New York Daily News writer Stefan Bondy from calling in to a teleconference, saying some media members had it out for the team.”There are certain journalists, right, that, you know, actually wish ill will towards the team,” Dolan said in March, via CBS Sports. “They don’t want to see the team win. They don’t want to see the team be successful. They have their own personal axes to grind. They come in with the intent of, I mean, they’ve never written a positive story about the team.”The Knicks made headlines by selecting Duke star RJ Barrett with the No. 3 overall pick Thursday and acquiring the 47th pick, Ignas Brazdeikis, in a trade with the Kings.last_img read more


A safer estrogen therapy for women

first_img Email It’s been a controversial strategy for more than a decade: giving estrogen hormone replacement therapy (HRT) to women to treat hot flashes, depression, and menopause-induced dementia. Although the therapy often works, it can also cause cancer, heart disease, and stroke. Now, scientists have found a way to boost estrogen only in the brain, a success in rats that may translate to safer treatments for people.“This could be very applicable for women suffering from hot flashes or depression for whom estrogen therapy is really counter-indicated,” says neuropharmacologist Roberta Brinton of the University of Southern California in Los Angeles, who was not involved in the new work.When a woman naturally reaches menopause—most often in her 50s—or does so prematurely, for reasons such as a hysterectomy or cancer treatment, levels of estrogen in her body begin to plummet. The hormonal changes can cause hot flashes, depression, and, over time, contribute to women’s risk of developing dementia and osteoporosis. Throughout the latter half of the 20th century, physicians commonly prescribed estrogen HRT to women going through menopause to help ease this transition as well as prevent the long-term effects of estrogen deprivation. Around the turn of the century, though, researchers noticed that women on HRT had an increased risk of heart disease, uterine and breast cancers, and strokes, and doctors generally stopped prescribing the drugs. Even pills that combined estrogen with other hormones meant to alleviate those problems didn’t fare any better when it came to dangerous side effects. Researchers led by biochemist Laszlo Prokai of the University of North Texas Health Science Center in Fort Worth were studying the production of estrogen in the body when they realized that one estrogen-generating pathway was only active in the brain. A compound called 10β,17β-dihydroxyestra 1,4 dien-3-one (DHED), they found, relies on an enzyme in the brain to be converted from its “prodrug” form into the active form of estrogen; other organs in the body use different starting blocks to generate the hormone. That means that, theoretically, treating animals with DHED would only result in an estrogen increase in the brain, not in the heart, uterus, or breast tissue, where it can cause unwanted side effects.And indeed, when the researchers gave rats doses of DHED, estrogen levels in their brains increased, whereas levels elsewhere in the body remained stable. What’s more, in female rats lacking ovaries—prone to hot flashes, depression, memory problems, and stroke—DHED reversed these nervous system–linked menopause symptoms without any detectable impacts on the rest of the body, the scientists report online today in Science Translational Medicine.“Because this prodrug remains completely inactive everywhere else in the body, you can remedy the neurological and psychiatric symptoms associated with estrogen deficiency while avoiding side effects in the rest of the body,” Prokai says. DHED could be particularly useful in treating women who prematurely enter menopause after surgery, because they have the most drastic changes in hormone levels and often deal with symptoms for the longest, he points out. Prokai’s group has already launched nonhuman primate studies of the therapy.But although the drug holds promise for helping some women, such as those who have specific risk factors for cancer, Brinton says, it may not be an ideal first-line treatment for estrogen-deficiency in many others. “Specifically targeting the brain might have some potential advantages but you aren’t protecting against osteoporosis and other conditions associated with the loss of hormones,” Brinton says. “There are certainly organ systems other than the brain which benefit from estrogen.” Prodrugs specific to those other organs—such as bones—would have to be developed to boost estrogen elsewhere in the body, she says. Sign up for our daily newsletter Get more great content like this delivered right to you! Countrycenter_img Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Click to view the privacy policy. Required fields are indicated by an asterisk (*)last_img read more